ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Sampre Nutritions allotted 1,770,710 equity shares at ₹42 each to promoters upon unsecured loan conversion. This capital issuance totals ₹7.44 Crore.
Sampre Nutritions Limited conducted its 35th Annual General Meeting on September 4, 2026. Shareholders considered the adoption of financial statements and a revision in director remuneration.
Sampre Nutritions received BSE in-principal approval for a preferential issue of 17.71 lakh equity shares. The issue involves converting ₹7.44 Crore of unsecured loans into equity.
Sampre Nutritions Ltd has filed its quarterly shareholding pattern for the period ended December 31, 2025, as mandated by SEBI Regulation 31.
Sampre Nutritions has filed its Annual Report for the financial year 2025-26, including the notice for its 35th Annual General Meeting.
Sampre Nutritions Limited will hold its 35th Annual General Meeting on 04 September 2026 via video conferencing to transact ordinary and special business.
Sampre Nutritions Ltd reported revenue from operations of ₹14.8 Cr (+35.8% YoY) and net profit of ₹0.7 Cr (+0.0% YoY) for Q1 FY27.
Sampre Nutritions Limited scheduled a board meeting for August 5, 2026. The board will consider June 2026 quarterly results and director remuneration increases.
Sampre Nutritions has scheduled a board meeting for August 5, 2026. The board will consider Q1 results and a proposal to increase director remuneration.